Raymond James Trust’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$238K Buy
2,106
+155
+8% +$18K 0.01% 1164
2024
Q2
$241K Sell
1,951
-390
-17% -$48.8K 0.01% 1088
2024
Q1
$302K Sell
2,341
-153
-6% -$18.6K 0.01% 974
2023
Q4
$307K Sell
2,494
-75
-3% -$7.98K 0.01% 910
2023
Q3
$263K Buy
2,569
+140
+6% +$14.6K 0.01% 939
2023
Q2
$244K Buy
2,429
+118
+5% +$11.8K 0.01% 1004
2023
Q1
$237K Buy
2,311
+220
+11% +$23.7K 0.01% 983
2022
Q4
$215K Buy
+2,091
New +$212K 0.01% 1013
2022
Q3
Sell
-2,166
Closed -$207K 1094
2022
Q2
$207K Buy
+2,166
New +$211K 0.01% 993

Other funds holding IOSP

Raymond James Trust's IOSP Position: Q3 2024 in Review

Raymond James Trust increased its Innospec (IOSP) stake by 7.9% in Q3 2024, buying an estimated $18K and bringing the position to 2,106 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #1164.

Raymond James Trust first reported a position in IOSP in Q2 2022 and has held it in 9 quarters since. The position peaked at $307K in Q4 2023. 259 funds tracked by Wall St. Rank hold IOSP as of Q3 2024.

  • Raymond James Trust held 2,106 shares of Innospec worth $238K as of Q3 2024.
  • Raymond James Trust bought 155 Innospec shares in Q3 2024, an estimated $18K.
  • Innospec made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #1164 holding.
  • Raymond James Trust first reported a position in Innospec in Q2 2022 and has held it in 9 quarters since.
  • Raymond James Trust's Innospec position peaked at $307K in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Innospec as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.